Liu Cheng 4
4 · Estrella Immunopharma, Inc. · Filed Feb 14, 2025
Insider Transaction Report
Form 4
Liu Cheng
DirectorChief Executive Officer
Transactions
- Award
Incentive Share Option
2024-10-30+490,796→ 490,796 totalExercise: $0.81From: 2024-10-31Exp: 2034-10-29→ Common Stock (490,796 underlying) - Award
Nonstatutory Share Option
2024-10-30+509,204→ 509,203 totalExercise: $0.81From: 2024-10-31Exp: 2034-10-29→ Common Stock (509,204 underlying)
Footnotes (4)
- [F1]On October 30, 2024, the Board of Directors (the "Board") of Estrella Immunopharma, Inc. (the "Company"), awarded Mr. Cheng Liu an incentive share option grant of 490,796 shares.
- [F2]The incentive share options will vest on a schedule, with twenty-five percent (25%) of the award being immediately exercisable on the date of the grant, with the remaining seventy-five percent (75%) vesting in equal monthly installments over the subsequent thirty-six (36) months, with 1/48th of the total number of shares subject to the option vesting on each monthly anniversary of October 30, 2024.
- [F3]On October 30, 2024, the Board of the Company awarded Mr. Liu a nonstatutory shares option grant of 509,204 shares.
- [F4]The nonstatutory share options will vest on a schedule, with twenty-five percent (25%) of the award being immediately exercisable on the date of the grant, with the remaining seventy-five percent (75%) vesting in equal monthly installments over the subsequent thirty-six (36) months, with 1/48th of the total number of shares subject to the option vesting on each monthly anniversary of October 30, 2024.